相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。BET proteins: Biological functions and therapeutic interventions
Jiawei Guo et al.
PHARMACOLOGY & THERAPEUTICS (2023)
Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study
Helena A. K. Lapatto et al.
SCIENCE ADVANCES (2023)
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results
Shinya Rai et al.
HAEMATOLOGICA (2023)
Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
Martina Sandona et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Recent progress and structural analyses of domain-selective BET inhibitors
Anand Divakaran et al.
MEDICINAL RESEARCH REVIEWS (2023)
NAD+ repletion with niacin counteracts cancer cachexia
Marc Beltra et al.
NATURE COMMUNICATIONS (2023)
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism
Susanna Molinari et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2023)
Systemic study of selected histone deacetylase inhibitors in cardiac complications associated with cancer cachexia
Vivek Bora et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2022)
Epigenome-wide association study of sarcopenia: findings from the Hertfordshire Sarcopenia Study (HSS)
Elie Antoun et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)
Annual Review of Cancer Biology Targeting BET Bromodomains in Cancer
Patrick Trojer
ANNUAL REVIEW OF CANCER BIOLOGY (2022)
BET bromodomain inhibitors
Martin P. Schwalm et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2022)
Role of Glucocorticoid Signaling and HDAC4 Activation in Diaphragm and Gastrocnemius Proteolytic Activity in Septic Rats
Alvaro Moreno-Ruperez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Metabolic Remodeling Impacts the Epigenetic Landscape of Dental Mesenchymal Stem Cells
Haiyun Luo et al.
STEM CELLS INTERNATIONAL (2022)
Phase III MANIFEST-2: pelabresib plus ruxolitinib vs placebo plus ruxolitinib in JAK inhibitor treatment-naive myelofibrosis
Claire N. Harrison et al.
FUTURE ONCOLOGY (2022)
Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia
Laura Yedigaryan et al.
CELLS (2022)
Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review
Lara Vilar Fernandes et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)
Cancer cachexia: molecular mechanism and pharmacological management
Yonghua Li et al.
BIOCHEMICAL JOURNAL (2021)
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
Richard J. Mills et al.
CELL (2021)
Role of myokines and osteokines in cancer cachexia
Fabrizio Pin et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2021)
Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration
Marc Beltra et al.
CELLS (2021)
The mechanism by which noncoding RNAs regulate muscle wasting in cancer cachexia
Xueer Zhou et al.
PRECISION CLINICAL MEDICINE (2021)
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
Kunal Nepali et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
The BET family in immunity and disease
Nian Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
The autophagic-lysosomal and ubiquitin proteasome systems are simultaneously activated in the skeletal muscle of gastric cancer patients with cachexia
Ying Zhang et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2020)
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
Sophia G. Liva et al.
EMBO MOLECULAR MEDICINE (2020)
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Omer Gilan et al.
SCIENCE (2020)
Aging alters acetylation status in skeletal and cardiac muscles
Dongwook Yeo et al.
GEROSCIENCE (2020)
SIRT1-NOX4 signaling axis regulates cancer cachexia
Aneesha Dasgupta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
ACY-1215, a HDAC6 inhibitor, decreases the dexamethasone-induced suppression of osteogenesis in MC3T3-E1 cells
Na Wang et al.
MOLECULAR MEDICINE REPORTS (2020)
The evolving metabolic landscape of chromatin biology and epigenetics
Ziwei Dai et al.
NATURE REVIEWS GENETICS (2020)
Markers of inflammation and their association with muscle strength and mass: A systematic review and meta-analysis
Camilla S. L. Tuttle et al.
AGEING RESEARCH REVIEWS (2020)
BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy
Marco Segatto et al.
NATURE COMMUNICATIONS (2020)
MicroRNAs in Skeletal Muscle and Hints on Their Potential Role in Muscle Wasting During Cancer Cachexia
Gioacchino P. Marceca et al.
FRONTIERS IN ONCOLOGY (2020)
Bone and Muscle Crosstalk in Aging
Chen He et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Extraocular Muscle Reveals Selective Vulnerability of Type IIB Fibers to Respiratory Chain Defects Induced by Mitochondrial DNA Alterations
Rafael R. Oexner et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2020)
First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity
Sophie Postel-Vinay et al.
EUROPEAN JOURNAL OF CANCER (2019)
Elevated H3K27ac in aged skeletal muscle leads to increase in extracellular matrix and fibrogenic conversion of muscle satellite cells
Jiajian Zhou et al.
AGING CELL (2019)
Exercise preconditioning attenuates hind limb unloading-induced gastrocnemius muscle atrophy possibly via the HDAC4/Gadd45 axis in old rats
Toshinori Yoshihara et al.
EXPERIMENTAL GERONTOLOGY (2019)
Muscle-bone crosstalk and potential therapies for sarco-osteoporosis
GuoBin Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs
Rebecca L. McIntyre et al.
EMBO MOLECULAR MEDICINE (2019)
Bromodomain biology and drug discovery
Nilesh Zaware et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
Petros Grivas et al.
CANCER (2019)
Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations
Riccardo Ballaro et al.
FASEB JOURNAL (2019)
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
Nicolaas E. P. Deutz et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2019)
Functions and mechanisms of non-histone protein acetylation
Takeo Narita et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities
Eugenia Migliavacca et al.
NATURE COMMUNICATIONS (2019)
AMPK in skeletal muscle function and metabolism
Rasmus Kjobsted et al.
FASEB JOURNAL (2018)
Autophagy and mitophagy flux in young and aged skeletal muscle following chronic contractile activity
Heather N. Carter et al.
JOURNAL OF PHYSIOLOGY-LONDON (2018)
miRNA-23a/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk
Aiqing Zhang et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential
Shoya Inaba et al.
PLOS ONE (2018)
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
Jingyi Liu et al.
NATURE COMMUNICATIONS (2018)
Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review
Lluis Campins et al.
PHARMACOLOGY (2017)
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
Marco Segatto et al.
NATURE COMMUNICATIONS (2017)
Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice
Jacob L. Brown et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells
Amy E. Campbell et al.
SKELETAL MUSCLE (2017)
The long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA molecules
Bongyong Lee et al.
SCIENCE ADVANCES (2017)
BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
Thomas C. Roberts et al.
SCIENTIFIC REPORTS (2017)
Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome
Seol-Hee Kang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2017)
Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis
Marc Baud'huin et al.
BONE (2017)
One-carbon metabolism and epigenetics: understanding the specificity
Samantha J. Mentch et al.
DIET, SULFUR AMINO ACIDS, AND HEALTH SPAN (2016)
Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia
Rulin Sun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
HDAC4 mediates IFN-γ induced disruption of energy expenditure-related gene expression by repressing SIRT1 transcription in skeletal muscle cells
Mingming Fang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Mechanisms of metabolic dysfunction in cancer-associated cachexia
Michele Petruzzelli et al.
GENES & DEVELOPMENT (2016)
Regenerative decline of stem cells in sarcopenia
Pedro Sousa-Victor et al.
MOLECULAR ASPECTS OF MEDICINE (2016)
Autophagy maintains stemness by preventing senescence
Laura Garcia-Prat et al.
NATURE (2016)
Histological effects of givinostat in boys with Duchenne muscular dystrophy
Paolo Bettica et al.
NEUROMUSCULAR DISORDERS (2016)
Impaired regeneration: A role for the muscle microenvironment in cancer cachexia
Erin E. Talbert et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways
Rafael Barreto et al.
FRONTIERS IN PHYSIOLOGY (2016)
The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging
Michael E. Walsh et al.
AGING CELL (2015)
Acetyl Coenzyme A: A Central Metabolite and Second Messenger
Federico Pietrocola et al.
CELL METABOLISM (2015)
Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression
Philipp Du Bois et al.
CIRCULATION RESEARCH (2015)
Cachexia and sarcopenia: mechanisms and potential targets for intervention
Josep M. Argiles et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Trichostatin A, a histone deacetylase inhibitor, modulates unloaded-induced skeletal muscle atrophy
Sylvie Dupre-Aucouturier et al.
JOURNAL OF APPLIED PHYSIOLOGY (2015)
Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
Yu-Chou Tseng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Muscle wasting in disease: molecular mechanisms and promising therapies
Shenhav Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
HISTONE DEACETYLASES IN BONE DEVELOPMENT AND SKELETAL DISORDERS
Elizabeth W. Bradley et al.
PHYSIOLOGICAL REVIEWS (2015)
Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy
Giulia Milan et al.
NATURE COMMUNICATIONS (2015)
Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations
Fabrizio Pin et al.
ONCOTARGET (2015)
Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
Yu-Chou Tseng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay
H. Robert Bergen et al.
SKELETAL MUSCLE (2015)
Histone Deacetylase 6 Is a FoxO Transcription Factor-dependent Effector in Skeletal Muscle Atrophy
Francesca Ratti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Mitochondrial energetics is impaired in vivo in aged skeletal muscle
Gilles Gouspillou et al.
AGING CELL (2014)
Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia
Sarah M. Judge et al.
BMC CANCER (2014)
Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review
Sumbul Ali et al.
GERONTOLOGY (2014)
NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis
Jonathan D. Brown et al.
MOLECULAR CELL (2014)
Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation
Friederike Itzen et al.
NUCLEIC ACIDS RESEARCH (2014)
Negative Auto-Regulation of Myostatin Expression is Mediated by Smad3 and MicroRNA-27
Craig McFarlane et al.
PLOS ONE (2014)
Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition
Ronen Marmorstein et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway
M. Sandri et al.
BIOGERONTOLOGY (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging
Ana P. Gomes et al.
CELL (2013)
The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy
Valentina Proserpio et al.
GENES & DEVELOPMENT (2013)
Mitochondrial dysfunction and sarcopenia of aging: From signaling pathways to clinical trials
Emanuele Marzetti et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
SIRT1 Protein, by Blocking the Activities of Transcription Factors FoxO1 and FoxO3, Inhibits Muscle Atrophy and Promotes Muscle Growth
Donghoon Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
Wei A. He et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
Anna C. Belkina et al.
JOURNAL OF IMMUNOLOGY (2013)
Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat
Silvia Consalvi et al.
MOLECULAR MEDICINE (2013)
HDAC inhibitors in kidney development and disease
Lauren L. Brilli et al.
PEDIATRIC NEPHROLOGY (2013)
被撤回的出版物: Myostatin is a novel tumoral factor that induces cancer cachexia (Retracted article. See vol. 473, pg. 1111, 2016)
Sudarsanareddy Lokireddy et al.
BIOCHEMICAL JOURNAL (2012)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Kenneth C. H. Fearon et al.
CELL METABOLISM (2012)
NCoR1 Is a Conserved Physiological Modulator of Muscle Mass and Oxidative Function
Hiroyasu Yamamoto et al.
CELL (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis
Maria M. Mihaylova et al.
CELL (2011)
Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells
Mehdi Shakibaei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Serum Concentrations of Myostatin and Myostatin-Interacting Proteins Do Not Differ Between Young and Sarcopenic Elderly Men
A. Ratkevicius et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
Myostatin Induces Degradation of Sarcomeric Proteins through a Smad3 Signaling Mechanism During Skeletal Muscle Wasting
Sudarsanareddy Lokireddy et al.
MOLECULAR ENDOCRINOLOGY (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
Andrea Bonetto et al.
PLOS ONE (2011)
Sarcopenia: European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2010)
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
Margaret E. Benny Klimek et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Xiaolan Zhou et al.
CELL (2010)
Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases
Viviana Moresi et al.
CELL (2010)
Skeletal muscle autophagy and apoptosis during aging: Effects of calorie restriction and life-long exercise
Stephanie Eva Wohlgemuth et al.
EXPERIMENTAL GERONTOLOGY (2010)
Muscle Wasting in Aged, Sarcopenic Rats Is Associated with Enhanced Activity of the Ubiquitin Proteasome Pathway
Mikael Altun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Muscle Wasting and Impaired Myogenesis in Tumor Bearing Mice Are Prevented by ERK Inhibition
Fabio Penna et al.
PLOS ONE (2010)
Smad2 and 3 transcription factors control muscle mass in adulthood
Roberta Sartori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Deacetylase Inhibitors Modulate the Myostatin/Follistatin Axis without Improving Cachexia in Tumor-Bearing Mice
A. Bonetto et al.
CURRENT CANCER DRUG TARGETS (2009)
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Carles Canto et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Vorinostat in solid and hematologic malignancies
David Siegel et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Higher Inflammatory Marker Levels in Older Persons: Associations With 5-Year Change in Muscle Mass and Muscle Strength
Laura A. Schaap et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2009)
Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA
Bo Huang et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Carles Canto et al.
NATURE (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C-elegans
Eric L. Greer et al.
CURRENT BIOLOGY (2007)
Antagonism of myostatin enhances muscle regeneration during sarcpenia
Victoria Siriett et al.
MOLECULAR THERAPY (2007)
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Sibylle Jaeger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α
Zachary Gerhart-Hines et al.
EMBO JOURNAL (2007)
Discovery and development of SAHA as an anticancer agent
P. A. Marks
ONCOGENE (2007)
PGC-1α a protects skeletal muscle from atrophy by suppressing Fox03 action and atrophy-specific gene transcription
Marco Sandri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors
G. C. Minetti et al.
NATURE MEDICINE (2006)
Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle
Stephan Clavel et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2006)
Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle
Erik Edstrom et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)
Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids
CS Katsanos et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2005)
SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α
S Nemoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Muscle fiber-specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction
T Phillips et al.
FASEB JOURNAL (2005)
Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin
S Iezzi et al.
DEVELOPMENTAL CELL (2004)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle
D Cuthbertson et al.
FASEB JOURNAL (2004)
Gene expression profile of aging in human muscle
S Welle et al.
PHYSIOLOGICAL GENOMICS (2003)
Tumor necrosis factor-regulated biphasic activation of NF-κB is required for cytokine-induced loss of skeletal muscle gene products
KJ Ladner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases
S Iezzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
MD Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of ubiquitin ligases required for skeletal muscle atrophy
SC Bodine et al.
SCIENCE (2001)
A dynamic role for HDAC7 in MEF2-mediated muscle differentiation
U Dressel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
TA McKinsey et al.
NATURE (2000)
Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases
JR Lu et al.
MOLECULAR CELL (2000)
Oxidative capacity and ageing in human muscle
KE Conley et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases
JR Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)